Search results for: 'research area jak stat signaling egfr'
-
B1103 Mutant EGFR inhibitorSummary: Selective Mutated EGFR inhibitor -
C3327 EGFR InhibitorSummary: EGFR inhibitor -
F1411 Anti-LGR5 & EGFR Antibody (Petosemtamab)Summary: Anti-LGR5 & EGFR Antibody (Petosemtamab) -
B1104 AZD-92911 CitationTarget: EGFRSummary: Mutated forms EGFR inhibitor -
L1026 DiscoveryProbe™ Neuronal Signaling Library1 CitationSummary: A unique collection of 556 neuronal signaling-related small molecules for neuroscience reasearch. -
L1044 DiscoveryProbe™ NF-κB Signaling LibrarySummary: A unique collection of 73 NF-κB inhibitors for NF-κB signaling pathway research. -
BA6330 LazertinibSummary: A potent, reversible, orally available, blood-brain barrier-crossing, mutant-selective, third-generation tyrosine kinase inhibitor. - BA4926 JAK-IN-26Summary: JAK-IN-26 is an orally active inhibitor with a favorable pharmacokinetic profile.
-
A1393 WZ8040Target: EGFRSummary: EGFR T790M inhibitor,irreversible amd potent - BA6368 EAI001Summary: EAI001 is a potent selective mutant epidermal growth factor receptor variant inhibitor.